Man at home having a headache in front of laptop_AS

NICE guideline

NICE headache guideline


This easy-to-read summary of NICE's guideline explores the diagnosis and management of tension, migraine, cluster, and medication overuse headaches

Syda Productions cannabis cannabidiol doctor

NICE guideline

NICE cannabis medicines guideline


Covering prescribing of cannabis-based medicines for people with intractable nausea and vomiting, chronic pain, spasticity, and severe treatment-resistant epilepsy


Independent professional body guideline

Self Care Forum headache and migraine fact sheet


A summary of recommendations for advising patients and the public on managing headache and migraine

maroke tired headache anaemia faint

NICE guideline

NICE neuropathic pain guideline


This summary of the NICE guidance covers the key principles of care, treatment of neuropathic pain, and treatment of trigeminal neuralgia.

Man with neck pain_AS

SIGN guideline

SIGN chronic pain guideline


This easy-to-read summary of SIGN's guideline describes pharmacological, psychological, and alternative approaches to the management of chronic pain.

Blue outline image person having a migraine_AS

SIGN guideline

SIGN migraine guideline


This Guidelines summary covers the pharmacological options for migraines, medication overuse headache, preventative treatment, and a treatment pathway

Sandor Kasco hands palliative care holding

NICE guideline

NICE palliative care guideline


This brief summary of NICE’s guideline on prescribing opioids in palliative care includes a care pathway algorithm, dose titration, and routes of delivery.

Resource hub

  • Migraine diary

Educational resources

Nurofen Express concise consultation card - digital


Contains promotional content by Reckitt

This concise consultation card was developed by Guidelines for Pharmacy  in partnership with Reckitt. 
Essential information and adverse reporting details are included.
RB-M-48255  October 2021

Management of opioid-induced constipation

The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)

Commissioned by Sandoz Limited

This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd. Information intended for UK healthcare professionals only. 
View prescribing information

UK/MKT/RZM/20-0029f October 2020